Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Chukwuka Didigu, MD, PhD

    TitleResident Physician
    SchoolUCSF School of Medicine
    Address401 Parnassus Ave, LangPorter
    San Francisco CA 94143
    vCardDownload vCard

      Collapse ORNG Applications 
      Collapse Featured Publications

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Didigu C, Doms R. Gene therapy targeting HIV entry. Viruses. 2014; 6(3):1395-409. PMID: 24662607; PMCID: PMC3970157.
      2. Petersen J, Drake MJ, Bruce EA, Riblett AM, Didigu CA, Wilen CB, Malani N, Male F, Lee FH, Bushman FD, Cherry S, Doms RW, Bates P, Briley K. The major cellular sterol regulatory pathway is required for Andes virus infection. PLoS Pathog. 2014 Feb; 10(2):e1003911. PMID: 24516383; PMCID: PMC3916400.
      3. Didigu CA, Wilen CB, Wang J, Duong J, Secreto AJ, Danet-Desnoyers GA, Riley JL, Gregory PD, June CH, Holmes MC, Doms RW. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood. 2014 Jan 2; 123(1):61-9. PMID: 24162716; PMCID: PMC3879906.
      4. Singer EM, Shin DB, Nattkemper LA, Benoit BM, Klein RS, Didigu CA, Loren AW, Dentchev T, Wysocka M, Yosipovitch G, Rook AH. IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus. J Invest Dermatol. 2013 Dec; 133(12):2783-5. PMID: 23698099.
        View in: PubMed
      5. Wojcechowskyj JA, Didigu CA, Lee JY, Parrish NF, Sinha R, Hahn BH, Bushman FD, Jensen ST, Seeholzer SH, Doms RW. Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entry. Cell Host Microbe. 2013 May 15; 13(5):613-23. PMID: 23684312; PMCID: PMC4104530.
      6. Parker ZF, Iyer SS, Wilen CB, Parrish NF, Chikere KC, Lee FH, Didigu CA, Berro R, Klasse PJ, Lee B, Moore JP, Shaw GM, Hahn BH, Doms RW. Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. J Virol. 2013 Mar; 87(5):2401-11. PMID: 23269796; PMCID: PMC3571396.
      7. Richardson MW, Jadlowsky J, Didigu CA, Doms RW, Riley JL. Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection. J Immunol. 2012 Oct 15; 189(8):3815-21. PMID: 22988032; PMCID: PMC3466370.
      8. Zheng X, Xu C, Smith AO, Stratman AN, Zou Z, Kleaveland B, Yuan L, Didiku C, Sen A, Liu X, Skuli N, Zaslavsky A, Chen M, Cheng L, Davis GE, Kahn ML. Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth. Dev Cell. 2012 Aug 14; 23(2):342-55. PMID: 22898778; PMCID: PMC3743537.
      9. Didigu CA, Doms RW. Novel approaches to inhibit HIV entry. Viruses. 2012 Feb; 4(2):309-24. PMID: 22470838; PMCID: PMC3315218.
      10. Tilton JC, Wilen CB, Didigu CA, Sinha R, Harrison JE, Agrawal-Gamse C, Henning EA, Bushman FD, Martin JN, Deeks SG, Doms RW. A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5. J Virol. 2010 Oct; 84(20):10863-76. PMID: 20702642; PMCID: PMC2950574.
      Chukwuka's Networks
      Related Concepts
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Related Authors
      People who share related concepts with this person.
      Back to TOP